[HTML][HTML] Small molecule-based prodrug targeting prostate specific membrane antigen for the treatment of prostate cancer

X Wang, A Shirke, E Walker, R Sun, G Ramamurthy… - Cancers, 2021 - mdpi.com
Simple Summary Currently, there is no effective treatment that can cure metastatic prostate
cancer. Various pros-tate specific membrane antigen (PSMA)-targeted radioimaging and …

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer.

X Wang, A Shirke, E Walker, R Sun… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Currently, there is no effective treatment that can cure metastatic
prostate cancer. Various pros-tate specific membrane antigen (PSMA)-targeted …

Small molecule-based prodrug targeting prostate specific membrane antigen for the treatment of prostate cancer

X Wang, A Shirke, E Walker, R Sun, G Ramamurthy… - Cancers, 2021 - hero.epa.gov
Metastatic castration-resistant prostate cancer poses a serious clinical problem with poor
outcomes and remains a deadly disease. New targeted treatment options are urgently …

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer

X Wang, A Shirke, E Walker, R Sun… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Metastatic castration-resistant prostate cancer poses a serious clinical problem with poor
outcomes and remains a deadly disease. New targeted treatment options are urgently …

[PDF][PDF] Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer. Cancers 2021, 13, 417

X Wang, A Shirke, E Walker, R Sun, G Ramamurthy… - 2021 - pdfs.semanticscholar.org
Metastatic castration-resistant prostate cancer poses a serious clinical problem with poor
outcomes and remains a deadly disease. New targeted treatment options are urgently …

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer. Cancers 2021, 13, 417

X Wang, A Shirke, E Walker, R Sun, G Ramamurthy… - 2021 - search.proquest.com
Metastatic castration-resistant prostate cancer poses a serious clinical problem with poor
outcomes and remains a deadly disease. New targeted treatment options are urgently …

[HTML][HTML] Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer

X Wang, A Shirke, E Walker, R Sun, G Ramamurthy… - Cancers, 2021 - ncbi.nlm.nih.gov
Metastatic castration-resistant prostate cancer poses a serious clinical problem with poor
outcomes and remains a deadly disease. New targeted treatment options are urgently …

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer

X Wang, A Shirke, E Walker, R Sun, G Ramamurthy… - Cancers, 2021 - cir.nii.ac.jp
抄録< jats: p> Metastatic castration-resistant prostate cancer poses a serious clinical
problem with poor outcomes and remains a deadly disease. New targeted treatment options …

[PDF][PDF] Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer. Cancers 2021, 13, 417

X Wang, A Shirke, E Walker, R Sun, G Ramamurthy… - 2021 - academia.edu
Metastatic castration-resistant prostate cancer poses a serious clinical problem with poor
outcomes and remains a deadly disease. New targeted treatment options are urgently …

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer.

X Wang, A Shirke, E Walker, R Sun, G Ramamurthy… - Cancers, 2021 - europepmc.org
Metastatic castration-resistant prostate cancer poses a serious clinical problem with poor
outcomes and remains a deadly disease. New targeted treatment options are urgently …